Sorrento Presents Preliminary Results of STI-2020 Against COVID-19
Shots: Celyad to get hold of Horizon’s shRNA technology for generation and development of allogenic CAR-T therapies shRNA (Short hairpin) technology is based on DNA and contains a selectable marker to allow elimination of cells that didn’t transfected or transduced Celyad’s novel CYAD-101 is a non-gene-edited allogeneic CAR-t candidate, NKG2D-based is developed by using the […]Read More
